Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
AlloVir Inc
ALVR
$
21.83
-5.9%
Tue March 23rd, 2021
12:18
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Digest
The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO
Benzinga
Sun January 24th, 2021
21:35
IPO
Analysis
U.S. IPO Week Ahead: Diverse 8 IPO Week Features 3 Billion-Dollar Deals
Seeking Alpha
Sat September 5th, 2020
13:00
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Analysis
What Insiders Have To Say About This All-Time High - August 2020 Insider Update
Seeking Alpha
Mon August 24th, 2020
11:31
Analysis
AlloVir initiated at overweight with $50 price target at JP Morgan
MarketWatch
Sun August 23rd, 2020
09:37
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
IPO
Analysis
U.S. IPO Week Ahead: Chinese EV's Billion-Dollar Deal Closes Out Summer In A 2-IPO Week
Seeking Alpha
Sat August 22nd, 2020
12:12
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Analysis
Stocks To Watch: Spotlight On Palo Alto Networks, Best Buy And Xpeng Motors
Seeking Alpha
Sun July 26th, 2020
16:18
IPO
Analysis
IPO Update: AlloVir Proposes Terms For $251 Million IPO
Seeking Alpha
Sat July 25th, 2020
12:52
IPO
Analysis
U.S. IPO Week Ahead: Tax Software Leads A Diverse 7-IPO Week
Seeking Alpha
Sat July 18th, 2020
13:13
IPO
Analysis
U.S. IPO Week Ahead: Software Provider Jamf Takes The Spotlight In A Diverse 4-IPO Week
Seeking Alpha
Thu July 16th, 2020
19:38
IPO
Analysis
AlloVir Seeks IPO For Anti-Viral Pipeline Development
Seeking Alpha
Sun July 12th, 2020
12:22
IPO
Analysis
Digest
U.S. IPO Weekly Recap: Preclinical Biotech Nkarta Pops 166% In A 5 IPO Week
Seeking Alpha
